Bio-Me has employed Dr. Anne-Grethe Reichelt as part of the company’s plan to widen commercial adoption of their existing product portfolio and launch new products under development. ...
Bio-Me has joined MTIG. Group members work together to accelerate microbiome-based drug development and expand availability of approved microbiome therapies to patients....
Bio-Me has appointed a new CEO as part of the company’s strategic plan to be positioned as a leader in the microbiome-based Precision Medicine space....
Bio-Me has announced a major board restructuring that will support the Company during its new phase of development....
Bio-Me today announced that a new Board of Directors has been approved by the general assembly.
...
